Role of GABA in anxiety and depression
Depression and Anxiety2006Vol. 24(7), pp. 495–517
Citations Over TimeTop 1% of 2006 papers
Abstract
This review assesses the parallel data on the role of gamma-aminobutyric acid (GABA) in depression and anxiety. We review historical and new data from both animal and human experimentation which have helped define the key role for this transmitter in both these mental pathologies. By exploring the overlap in these conditions in terms of GABAergic neurochemistry, neurogenetics, brain circuitry, and pharmacology, we develop a theory that the two conditions are intrinsically interrelated. The role of GABAergic agents in demonstrating this interrelationship and in pointing the way to future research is discussed.
Related Papers
- → Toxoplasma gondii Infections Alter GABAergic Synapses and Signaling in the Central Nervous System(2015)140 cited
- → Rates of Comorbid Anxiety and Depression in Patients With Age-Related Macular Degeneration(2019)5 cited
- Antiepileptics from gamma-aminobutyric acid.(1994)
- → Possible occurrence of ornithine-?-aminotransferase in gabaergic neurons(1984)6 cited
- Influence of Health Education on Type 2 Diabetic Inpatients' Anxiety and Depression(2013)